First-in-class P2X3 receptor antagonist shows promise for chronic cough treatment Presented ByProf. Lorcan McGarvey , Queen's University Belfast TrialPhase 3, COUGH-1, COUGH-2 ConferenceERS 2020 TypePeer-reviewed article 29 October 2020 16:52